Dr. Jeffrey R. Jay, M.D. »

Dianthus Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-03-31 $19M 625k 30.00

More positions owned by Dr. Jeffrey R. Jay, M.D.

Neurogene (NGNE)
Alpine Immune Sciences (ALPN)
Urogen Pharma (URGN)
Abivax Sa Sponsored Ads (ABVX)
Evolus (EOLS)
Pliant Therapeutics (PLRX)
Apogee Therapeutics (APGE)
Aerovate Therapeutics (AVTE)
Miragen Therapeutics (VRDN)
Anaptysbio Inc Common (ANAB)
Esperion Therapeutics (ESPR)
Insmed Com Par $.01 (INSM)
Arcellx Common Stock (ACLX)
Xenon Pharmaceuticals (XENE)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Tang Capital Management

View all funds holding Dianthus Therapeutics